Compass Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $48,473,000.
Profit Margin
| 2018 | 0 | -38.28M | |
|---|---|---|---|
| 2019 | 0 | -34.74M | |
| 2020 | 0 | -29.5M | |
| 2021 | 0 | -82.55M | |
| 2022 | 0 | -36.79M | |
| 2023 | 0 | -42.49M |
CMPX Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.89M | 1.90M | 1.62M | 2.40M | 2.12M | 0 |
Gross profit | -1.89M | -1.90M | -1.62M | -2.40M | -2.12M | 0 |
Operating exp. | ||||||
Research and development | 37.42M | 29.99M | 20.33M | 14.90M | 22.44M | 27.09M |
Selling and marketing | 11.03M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 48.47M | 41.65M | 31.26M | 27.81M | 34.05M | 38.31M |
Operating income | -50.36M | -41.65M | -81.88M | -27.81M | -34.05M | -38.31M |
Other income (expenses), net | 7.86M | 2.43M | -299K | -1.65M | -601K | 233K |
Income before tax | -42.49M | -39.22M | -82.18M | -29.46M | -34.65M | -38.18M |
Income tax expense | 0 | -2.43M | 370K | 32K | 91K | 103K |
Net income | -42.49M | -36.79M | -82.55M | -29.5M | -34.74M | -38.28M |
Earnings per share | ||||||
Basic EPS | -0.33 | -0.35 | -1.31 | -0.96 | -0.67 | -0.73 |
Diluted EPS | -0.33 | -0.35 | -1.31 | -0.96 | -0.67 | -0.73 |
| Data source | Data source | Data source | Data source |